Class ii phosphoinositide 3-kinase C2alpha: What we learned so far

International Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 2, 2011, Pages 168-182

  Mazza, Simona ^a   Maffucci, Tania ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Exocytosis; Glucose transport; Insulin secretion; Neurosecretion; Phosphoinositide 3 kinase; Phosphoinositides

Indexed keywords

GLUCOSE TRANSPORTER 4; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE C2ALPHA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ARTICLE; BREAST CANCER; CELL SURVIVAL; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME MECHANISM; EXOCYTOSIS; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; INSULIN RELEASE; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; NEUROSECRETORY CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ADENOCARCINOMA; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

DROSOPHILA MELANOGASTER; MAMMALIA;

EID: 79958047958     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
2. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010;11:329-41.
3. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Gen 2006;7:606-19.
4. Wong KK, Engelman JA, Cantley LC. Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 2010;20:87-90.
5. Falasca M. PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 2010;16:1410-6.
6. Foukas LC, Withers DJ. Phosphoinositide signaling pathways in metabolic regulation. Curr Top Microbiol Immunol 2010;346:115-41.
7. Falasca M, Maffucci T. Role of class II phosphoinositide 3-kinase in cell signalling. Biochem Soc Trans 2007;35:211-4.
8. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJ, Okkenhaug K, Vanhaesebroeck B. The p110beta isoform of phosphoinositide 3- kinase signals downstream of G proteincoupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci U S A 2008;105:8292-7.
9. Backer JM. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J 2008;410:1-17.
10. MacDougall LK, Domin J, Waterfield MD. A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction. Curr Biol 1995;5:1404-15.
11. Brown RA, Domin J, Arcaro A, Waterfield MD, Shepherd PR. Insulin activates the alpha isoform of class II phosphoinositide 3-kinase. J Biol Chem 1999;274:14529-32.
12. Arcaro A, Zvelebil MJ, Wallasch C, Ullrich A, Waterfield MD, Domin J. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol Cell Biol 2000;20:3817-30.
13. Arcaro A, Khanzada UK, Vanhaesebroeck B, Tetley TD, Waterfield MD, Seckl MJ. Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J 2002;21:5097-108.
14. Falasca M, Hughes WE, Dominguez V, Sala G, Fostira F, Fang MQ, Cazzolli R, Shepherd PR, James DE, Maffucci T. The role of phosphoinositide 3-kinase C2alpha in insulin signaling. J Biol Chem 2007;282:28226-36.
15. Maffucci T, Cooke FT, Foster FM, Traer CJ, Fry MJ, Falasca M. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J Cell Biol 2005;169:789-99.
16. Arcaro A, Volinia S, Zvelebil MJ, Stein R, Watton SJ, Layton MJ, Gout I, Ahmadi K, Downward J, Waterfield MD. Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity. J Biol Chem 1998;273:33082-90.
17. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, Stein RC, Waterfield MD. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J 1997;326:139-47.
18. Virbasius JV, Guilherme A, Czech MP. Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J Biol Chem 1996;271:13304-7.
19. Misawa H, Ohtsubo M, Copeland NG, Gilbert DJ, Jenkins NA, Yoshimura A. Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. Biochem Biophys Res Commun 1998;244:531-9.
20. Gaidarov I, Smith ME, Domin J, Keen JH. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrinmediated membrane trafficking. Mol Cell 2001;7:443-9.
21. Maffucci T, Brancaccio A, Piccolo E, Stein RC, Falasca M. Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J 2003;22:4178-89.
22. Falasca M, Maffucci T. Rethinking phosphatidylinositol 3-monophosphate. Biochim Biophys Acta 2009;1793:1795-803.
23. Meunier FA, Osborne SL, Hammond GR, Cooke FT, Parker PJ, Domin J, Schiavo G. Phosphatidylinositol 3-kinase C2alpha is essential for ATPdependent priming of neurosecretory granule exocytosis. Mol Biol Cell 2005;16:4841-51.
24. Wen PJ, Osborne SL, Morrow IC, Parton RG, Domin J, Meunier FA. Ca2+-regulated pool of phosphatidylinositol-3-phosphate produced by phosphatidylinositol 3-kinase C2alpha on neurosecretory vesicles. Mol Biol Cell 2008;19:5593-603.
25. Osborne SL, Wen PJ, Boucheron C, Nguyen HN, Hayakawa M, Kaizawa H, Parker PJ, Vitale N, Meunier FA. PIKfyve negatively regulates exocytosis in neurosecretory cells. J Biol Chem 2008;283:2804-13.
26. Leibiger B, Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO, Leibiger IB. Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucosestimulated insulin secretion. FASEB J 2010;24:1824-37.
27. Cui ZG, Hong NY, Kang HK, Lee DH, Lee YK, Park DB. The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB. Mol Cell Biochem 2011;346:95-101.
28. Elis W, Triantafellow E, Wolters NM, Sian KR, Caponigro G, Borawski J, Gaither LA, Murphy LO, Finan PM, Mackeigan JP. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. Mol Cancer Res 2008;6:614-23.
29. Stahelin RV, Karathanassis D, Bruzik KS, Waterfield MD, Bravo J, Williams RL, Cho W. Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2alpha. J Biol Chem 2006;281:39396-406.
30. Ursø B, Brown RA, O'Rahilly S, Shepherd PR, Siddle K. The alpha-isoform of class II phosphoinositide 3-kinase is more effectively activated by insulin receptors than IGF receptors, and activation requires receptor NPEY motifs. FEBS Lett 1999;460:423-6.
31. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, Sugimoto N, Inoki I, Kimura T, Kuwaki T, Takuwa Y. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 2006;394:581-92.
32. Dominguez V, Raimondi C, Somanath S, Bugliani M, Loder MK, Edling CE, Divecha N, da Silva-Xavier G, Marselli L, Persaud SJ, Turner MD, Rutter GA, Marchetti P, Falasca M, Maffucci T. Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells. J Biol Chem 2011;286:4216-25.
33. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001;7(3):559-70.
34. Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, Tronchere H, Portis F, Rusconi S, Payrastre B, Laporte J, Van Obberghen E. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 2003;17:2448-60.
35. Ishiki M, Randhawa VK, Poon V, Jebailey J, Klip A. Insulin regulates the membrane arrival, fusion, and C-terminal unmasking of glucose transporter-4 via distinct phosphoinositides. J Biol Chem 2005;280:28792-802.
36. Kanda H, Tamori Y, Shinoda H, Yoshikawa M, Sakaue M, Udagawa J, Otani H, Tashiro F, Miyazaki J, Kasuga M. Adipocytes from Munc18cnull mice show increased sensitivity to insulinstimulated GLUT4 externalization. J Clin Invest 2005;115:291-301.
37. Kong AM, Horan KA, Sriratana A, Bailey CG, Collyer LJ, Nandurkar HH, Shisheva A, Layton MJ, Rasko JE, Rowe T, Mitchell CA. Phosphatidylinositol 3-phosphate [PtdIns3P] is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane. Mol Cell Biol 2006;26:6065-81.
38. Lodhi IJ, Bridges D, Chiang SH, Zhang Y, Cheng A, Geletka LM, Weisman LS, Saltiel AR. Insulin stimulates phosphatidylinositol 3-phosphate production via the activation of Rab5. Mol Biol Cell 2008;19:2718-28.
39. Brunner Y, Couté Y, Iezzi M, Foti M, Fukuda M, Hochstrasser DF, Wollheim CB, Sanchez JC. Proteomics analysis of insulin secretory granules. Mol Cell Proteomics 2007;6:1007-17.
40. Dai S, Zhang Y, Weimbs T, Yaffe MB, Zhou D. Bacteria-generated PtdIns(3)P recruits VAMP8 to facilitate phagocytosis. Traffic 2007;8:1365-74.
41. Mima J, Wickner W. Phosphoinositides and SNARE chaperones synergistically assemble and remodel SNARE complexes for membrane fusion. Proc Natl Acad Sci U S A 2009;106:16191-6.
42. Mima J, Wickner W. Complex lipid requirements for SNARE- and SNARE chaperone-dependent membrane fusion. J Biol Chem 2009;284:27114-22.
43. Paul DS, Harmon AW, Winston CP, Patel YM. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 2003;376:625-32.
44. Logie LJ, Brown AE, Yeaman SJ, Walker M. Calpain inhibition and insulin action in cultured human muscle cells. Mol Genet Metab 2005;85:54-60.
45. Brown AE, Yeaman SJ, Walker M. Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells. Mol Genet Metab 2007;91:318-24.
46. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR, Turner MD. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol 2005;19:213-24.
47. MacDonald PE, Joseph JW, Yau D, Diao J, Asghar Z, Dai F, Oudit GY, Patel MM, Backx PH, Wheeler MB. Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase. Endocrinology 2004;145:4078-83.
48. Pigeau GM, Kolic J, Ball BJ, Hoppa MB, Wang YW, Rückle T, Woo M, Manning Fox JE, Mac-Donald PE. Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human beta-cells. Diabetes 2009;58:2084-92.
49. Kaneko K, Ueki K, Takahashi N, Hashimoto S, Okamoto M, Awazawa M, Okazaki Y, Ohsugi M, Inabe K, Umehara T, Yoshida M, Kakei M, Kitamura T, Luo J, Kulkarni RN, Kahn CR, Kasai H, Cantley LC, Kadowaki T. Class IA phosphatidylinositol 3-kinase in pancreatic β cells controls insulin secretion by multiple mechanisms. Cell Metab 2010;12:619-32.
50. Krag C, Malmberg EK, Salcini AE. PI3KC2α, a class II PI3K, is required for dynaminindependent internalization pathways. J Cell Sci 2010;123:4240-50.
51. Yoshioka K, Sugimoto N, Takuwa N, Takuwa Y. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rhoand Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Mol Pharmacol 2007;71:912-20.
52. Azam MA, Yoshioka K, Ohkura S, Takuwa N, Sugimoto N, Sato K, Takuwa Y. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle. J Pharmacol Exp Ther 2007;320:907-16.
53. Seok YM, Azam MA, Okamoto Y, Sato A, Yoshioka K, Maeda M, Kim I, Takuwa Y. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats. Hypertension 2010;56:934-41.
54. Ng SK, Neo SY, Yap YW, Karuturi RK, Loh ES, Liau KH, Ren EC. Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation. Biochem Biophys Res Commun 2009;387:310-15.
55. Kang S, Song J, Kang J, Kang H, Lee D, Lee Y, Park D. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death. Biochem Biophys Res Commun 2005;329:6-10.
56. Eun LY, Song BW, Cha MJ, Song H, Kim IK, Choi E, Chang W, Lim S, Choi EJ, Ham O, Lee SY, Byun KH, Jang Y, Hwang KC. Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infracted myocardium. Biochem Biophys Res Commun 2010;402:272-9.
57. Harris DP, Vogel P, Wims M, Moberg K, Humphries J, Jhaver KG, Dacosta CM, Shadoan MK, Xu N, Hansen GM, Balakrishnan S, Domin J, Powell DR, Oravecz T. Requirement for the class II phosphoinositide 3-kinase C2{alpha} in maintenance of glomerular structure and function. Mol Cell Biol 2011;31:63-80.
58. Edling CE, Selvaggi F, Buus R, Maffucci T, Di Sebastiano P, Friess H, Innocenti P, Kocher HM, Falasca M. Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin Cancer Res 2010;16:4928-37.
59. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd, Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007;104:16158-63.